Evidence map›Paper›PMID 28846685›Full record

ArticlePloS one2017

Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature.

Ajit Muley, Yoshi Odaka, Ian P Lewkowich, Shruti Vemaraju, Terry P Yamaguchi, Carrie Shawber, Belinda H Dickie, Richard A Lang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Microbial-Dependent Recruitment of Immature Myeloid Cells Promotes Intestinal Regeneration.Cellular and molecular gastroenterology and hepatology · 2024
    Article
  2. Review
  3. Article
  4. Review
  5. MyeloidFrontiers in endocrinology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ajit MuleyDepartment of OB-GYN, Columbia University Medical Center, Columbia University, New York City, New York, United States of America.
Yoshi OdakaVisual Systems Group, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
Ian P LewkowichDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
Shruti VemarajuVisual Systems Group, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
Terry P YamaguchiCancer and Developmental Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States of America.
Carrie ShawberDepartment of OB-GYN, Columbia University Medical Center, Columbia University, New York City, New York, United States of America.
Belinda H DickieDepartment of Surgery, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Richard A LangVisual Systems Group, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.ORCID http://orcid.org/0000-0002-5212-254X
Cincinnati Children's Hospital Medical Center · USColumbia University Irving Medical Center · USBoston Children's Hospital · USNational Cancer Institute · US

Funding

The Role of Wnt Genes in Vertebrate Development and CancerZIABC010345 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YAMAGUCHI, TERENCE · 2009 to 2025
$23.3M
Retinal Microglia and AngiogenesisR01EY021636 · NEI · CINCINNATI CHILDRENS HOSP MED CTR · PI LANG, RICHARD A. · 2012 to 2016
$1.9M
NEI NIH HHS R01 EY021636
6 · The paper itself

Abstract

Resident tissue myeloid cells play a role in many aspects of physiology including development of the vascular systems. In the blood vasculature, myeloid cells use VEGFC to promote angiogenesis and can use Wnt ligands to control vascular branching and to promote vascular regression. Here we show that myeloid cells also regulate development of the dermal lymphatic vasculature using Wnt ligands. Using myeloid-specific deletion of the WNT transporter Wntless we show that myeloid Wnt ligands are active at two distinct stages of development of the dermal lymphatics. As lymphatic progenitors are emigrating from the cardinal vein and intersomitic vessels, myeloid Wnt ligands regulate both their numbers and migration distance. Later in lymphatic development, myeloid Wnt ligands regulate proliferation of lymphatic endothelial cells (LEC) and thus control lymphatic vessel caliber. Myeloid-specific deletion of WNT co-receptor Lrp5 or Wnt5a gain-of-function also produce elevated caliber in dermal lymphatic capillaries. These data thus suggest that myeloid cells produce Wnt ligands to regulate lymphatic development and use Wnt pathway co-receptors to regulate the balance of Wnt ligand activity during the macrophage-LEC interaction.

Indexed as

AnimalsCell ProliferationDermisEndothelial CellsLymphangiogenesisLymphatic VesselsMiceMyeloid CellsWnt ProteinsWnt Signaling PathwayWnt Proteins

Identifiers

PMID28846685
PMCPMC5573294
OpenAlexW2748250948

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.